Safety of use of granulocyte colony stimulating factor during concurrent chemotherapy and thoracic radiotherapy in limited-stage small-cell lung cancer.

e20570Background: Small cell lung cancer (SCLC) comprises approximately 15% of all lung cancers with 5 year mortality > 90%. Early initiation of chemotherapy with radiotherapy is the current standa...